Related references
Note: Only part of the references are listed.Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo
Yun Dai et al.
BLOOD (2011)
CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
Victoria E. Anderson et al.
CANCER RESEARCH (2011)
A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis
Cheryl Jacobs et al.
HUMAN MOLECULAR GENETICS (2011)
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
Joyce O'Shaughnessy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining
Sheema Fnu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Victoria J. Weston et al.
BLOOD (2010)
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
A. A. Rodriguez et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1
Sarah A. Martin et al.
CANCER CELL (2010)
Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib
Siquan Chen et al.
CANCER RESEARCH (2010)
Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells
Ponnari Gottipati et al.
CANCER RESEARCH (2010)
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Samuel F. Bunting et al.
CELL (2010)
Small molecule inhibitors of DNA repair nuclease activities of APE1
David M. Wilson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy
Bernd Kaina et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
MRN and the race to the break
Agnieszka Rupnik et al.
CHROMOSOMA (2010)
DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
Brian M. Alexander et al.
CLINICAL CANCER RESEARCH (2010)
Perspective on the Pipeline of Drugs Being Developed with Modulation of DNA Damage as a Target
Ruth Plummer
CLINICAL CANCER RESEARCH (2010)
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Yun Dai et al.
CLINICAL CANCER RESEARCH (2010)
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
Asima Mukhopadhyay et al.
CLINICAL CANCER RESEARCH (2010)
Ku prevents Exo1 and Sgs1-dependent resection of DNA ends in the absence of a functional MRX complex or Sae2
Eleni P. Mimitou et al.
EMBO JOURNAL (2010)
Ku and DNA-dependent Protein Kinase Dynamic Conformations and Assembly Regulate DNA Binding and the Initial Non-homologous End Joining Complex
Michal Hammel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination
Anne Bothmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Raga Krishnakumar et al.
MOLECULAR CELL (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats
Bancinyane L. Sibanda et al.
NATURE (2010)
Maintaining genome stability at the replication fork
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Going Ape as an Approach to Cancer Therapeutics
Aditi Bapat et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Enhancing radiosensitivity Targeting the DNA repair pathways
Timothy J. Jorgensen
CANCER BIOLOGY & THERAPY (2009)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Mechanisms of Dealing with DNA Damage-Induced Replication Problems
Magda Budzowska et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2009)
DNA Repair in Mammalian Cells
A. B. Robertson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
DNA Repair in Mammalian Cells
T. Nouspikel
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2
Sarah A. Martin et al.
EMBO MOLECULAR MEDICINE (2009)
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Ana M. Mendes-Pereira et al.
EMBO MOLECULAR MEDICINE (2009)
The combined status of ATM and p53 link tumor development with therapeutic response
Hai Jiang et al.
GENES & DEVELOPMENT (2009)
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes
Terry J. Gaymes et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Terzah M. Horton et al.
MOLECULAR CANCER THERAPEUTICS (2009)
CUP Links DNA Double-Strand Break Sensing to Resection
Zhongsheng You et al.
MOLECULAR CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Complex landscapes of somatic rearrangement in human breast cancer genomes
Philip J. Stephens et al.
NATURE (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
Hiroshi Nishida et al.
NUCLEIC ACIDS RESEARCH (2009)
Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer
N. McCabe et al.
ONCOGENE (2009)
Rad52 promotes second-end DNA capture in double-stranded break repair to form complement-stabilized joint molecules
Amitabh V. Nimonkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
Surojit Sur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanism of eukaryotic homologous recombination
Joseph San Filippo et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
N. Bucher et al.
BRITISH JOURNAL OF CANCER (2008)
Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair
Xi Chen et al.
CANCER RESEARCH (2008)
A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity
Christopher J. Lord et al.
DNA REPAIR (2008)
Role and regulation of human XRCC4-like factor/Cernunnos
Kirsten Dahm
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex
Aude Dupre et al.
NATURE CHEMICAL BIOLOGY (2008)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The mechanism of human nonhomologous DNA end joining
Michael R. Lieber
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Proteasome function is required for DNA damage response and Fanconi anemia pathway activation
Celine Jacquemont et al.
CANCER RESEARCH (2007)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
The tandem BRCT domain of 53BP1 is not required for its repair function
Irene Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions
Steven R. Bartz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Modeling oncogenic translocations: Distinct roles for double-strand break repair pathways in translocation formation in mammalian cells
David M. Weinstock et al.
DNA REPAIR (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
DNA repair pathways in clinical practice: Lessons from pediatric cancer susceptibility syndromes
Richard D. Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao et al.
CANCER RESEARCH (2006)
The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair
SH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors
J Kortmansky et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
M Audebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
I Hickson et al.
CANCER RESEARCH (2004)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks
DW Chan et al.
GENES & DEVELOPMENT (2002)
Cell-based assays for identification of novel double-strand break-inducing agents
HM Dunstan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation
P Nghiem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
